AEVIS VICTORIA SA (AEVS) AI Stock Analysis

2 Followers

AEVIS VICTORIA SA

(Six Swiss:AEVS)

Select Model

Rating:52Neutral

Price Target:CHF 14.50▲(2.11% Upside)

Action:reiterated

Date:09/23/26

The score is held back most by weak and inconsistent profitability and high leverage despite strong revenue growth and improving operating cash flow. Technicals are supportive with a clear uptrend, but momentum is overheated (very high RSI/Stoch), raising near-term pullback risk. Valuation is pressured by a negative P/E, while the latest earnings call adds support through upbeat guidance, margin expansion, and deleveraging progress.

Positive Factors

Revenue Growth and Operating Cash FlowStrong multi-year revenue expansion, paired with consistently positive and improving operating cash flow, indicates that the healthcare portfolio is gaining scale and generating internal funding. This supports reinvestment and provides a durable cushion while management works to improve reported profitability.

Negative Factors

Persistent Net LossesSeveral years of net losses show that revenue growth has not yet translated into dependable company-wide earnings. Continued losses can limit retained capital, make performance more dependent on portfolio actions, and indicate that execution and cost pressures remain material despite recent operational improvements.

AEVIS VICTORIA SA (AEVS) vs. iShares MSCI Switzerland ETF (EWL)

Market Cap: CHF 1.21B
Dividend Yield: ―
Average Volume (3M): 37.13K
Price to Earnings (P/E): -62.9
Beta (1Y): -0.30
Revenue Growth: 14.88%
EPS Growth: -1004.05%
Country: Switzerland
Employees: 4,870
Sector: General
Sector Strength: 55
Industry: Medical - Care Facilities

AEVIS VICTORIA SA Business Overview & Revenue Model

Company Description

Aevis Victoria SA is a Swiss holding company with diversified interests spanning the healthcare, hospitality, lifestyle, and infrastructure sectors. Its operational structure is divided into key segments: Hospitals, Hospitality, Telemedicine, and Rea...

How the Company Makes Money

AEVIS VICTORIA SA makes money primarily through the operating performance and value creation of its healthcare portfolio companies. Its economic model generally consists of: (1) Operating income generated by its healthcare services holdings (e.g., re...

AEVIS VICTORIA SA Earnings Call Summary

Earnings Call Date:Sep 17, 2026(Q2-2026)|% Change Since:3.65%|Next Earnings Date:May 12, 2026

Earnings Call SentimentPositive

The call was predominantly positive. Management reported NAV growth, stronger profitability, significant margin expansion at Swiss Medical Network and ambulatory services, lower interest expense, deleveraging, progress in integrated care, and confidence in Viva's membership and breakeven targets. The main challenges were the more-than-50% NAV discount, geopolitical and regional hospitality pressures, loss-making ventures, and short-term profitability declines at turnaround hospitals and Réseau de l'Arc.

Positive Updates

Healthcare-Focused Investment Portfolio

Around 60% of AEVIS VICTORIA's investments are in healthcare, with hospitality representing 20% and infrastructure representing a bit more. The portfolio also includes Viva for integrated care, Genolier Innovation Hub for innovation, and Nescens for longevity.

Negative Updates

Historically High NAV Discount

The shares traded at a discount to NAV of more than 50%, described as unprecedented in the group's history.

Company Guidance

Management said healthcare profitability could improve from 16% to more than 20%, with a goal of reaching 23% margin and organic growth of 2%-3% a year; more than 50% of hospitals could and can reach more than the 25%-26% EBITDA margin, while ramp-up hospitals are around an EBITDA of 10%-20%. For integrated care, the medium-term goal is 15%-20%, the long-run potential is 25%-30%, and the aim is to double the amount of members every year; management was very confident of reaching the breakeven point of 10,000 members by the end of 2026 or early 2027. In hospitality, there is no occupancy target, occupancy is roughly 55%, and pricing is more important than occupancy at this stage, with confidence that the seasonal gap will be smaller. Réseau de l'Arc is expected to be in the positive field at the end of this year, Lindberg’s positive effects are expected next year, and Swiss Medical Network is expected to improve performance compared to the second half year of 2025, although the second part of the year is a bit weaker and not expected to be better than the first half.

AEVIS VICTORIA SA Financial Statement Overview

Summary

Revenue growth has been strong (about 696.6M in 2020 to about 1.13B in 2025) and operating cash flow is consistently positive and improving. However, profitability is inconsistent with net losses in most recent years (2023–2025) and the balance sheet is highly levered (debt roughly 0.95B–1.07B vs. equity about 0.47B–0.53B), which elevates financial risk.

Income Statement

45Neutral

Balance Sheet

38Negative

Cash Flow

52Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.20B	1.13B	1.01B	914.36M	1.03B	823.26M
Gross Profit	196.07M	193.03M	789.90M	170.09M	185.41M	137.56M
EBITDA	9.10M	24.91M	92.49M	49.06M	128.29M	83.47M
Net Income	-18.85M	-20.11M	-2.87M	-39.30M	58.81M	-4.26M
Balance Sheet
Total Assets	1.97B	1.91B	2.00B	1.86B	1.79B	1.73B
Cash, Cash Equivalents and Short-Term Investments	63.09M	28.98M	36.92M	80.71M	75.43M	63.42M
Total Debt	1.00B	949.83M	1.07B	1.01B	970.03M	841.27M
Total Liabilities	1.41B	1.35B	1.42B	1.32B	1.28B	1.14B
Stockholders Equity	509.39M	509.75M	530.85M	491.89M	469.34M	485.92M
Cash Flow
Free Cash Flow	22.46M	4.87M	-18.80M	-66.06M	40.28M	-24.07M
Operating Cash Flow	89.81M	72.56M	46.50M	42.67M	114.30M	33.53M
Investing Cash Flow	-81.34M	56.05M	-62.28M	35.56M	-56.82M	21.63M
Financing Cash Flow	31.13M	-136.51M	-28.06M	-72.95M	-45.46M	-57.31M

AEVIS VICTORIA SA Technical Analysis

Technical Analysis SentimentNeutral

Last Price14.20

Price Trends

50DMA14.42Negative

100DMA13.57Positive

200DMA13.48Positive

Market Momentum

MACD-0.09Positive

RSI41.15Neutral

STOCH63.49Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:AEVS, the sentiment is Neutral. The current price of 14.20 is below the 20-day moving average (MA) of 14.40, below the 50-day MA of 14.42, and above the 200-day MA of 13.48, indicating a neutral trend. The MACD of -0.09 indicates Positive momentum. The RSI at 41.15 is Neutral, neither overbought nor oversold. The STOCH value of 63.49 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CH:AEVS.

AEVIS VICTORIA SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

CH:AEVS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CH:BSLN	83Outperform	CHF 876.50M	16.71	―	―	4.74%	-28.96%
CH:MOVE	73Outperform	CHF 2.19B	30.55	16.40%	1.00%	7.51%	-20.13%
CH:GALE	70Outperform	CHF 4.49B	28.23	―	2.78%	6.48%	-17.25%
CH:DOCM	62Neutral	CHF 938.95M	-11.77	―	―	―	―
CH:MED	62Neutral	CHF 1.47B	90.00	―	―	29.92%	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
CH:AEVS	52Neutral	CHF 1.21B	-62.91	―	―	14.88%	-1004.05%

* General Sector Average

Performance Comparison

CH:AEVS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
CH:AEVS	AEVIS VICTORIA SA	14.20	1.40	10.94%
CH:DOCM	DocMorris AG	18.60	13.18	243.17%
CH:BSLN	Basilea Pharmaceutica	71.20	24.30	51.81%
CH:MOVE	Medacta Group Sa	109.60	-41.43	-27.43%
CH:GALE	Galenica AG	90.05	6.05	7.20%
CH:MED	Medartis Holding AG	108.00	31.50	41.18%

AEVIS VICTORIA SA Corporate Events

AEVIS’ Swiss Medical Network adds BENU pharmacies to Ticino care network

Oct 12, 2026

Swiss Medical Network, a subsidiary of AEVIS VICTORIA SA, has entered a partnership with PHOENIX Pharma Switzerland to integrate BENU pharmacies in Ticino into its Rete Sant’Anna integrated care network. This move adds pharmacies to an existing ecosy...

AEVIS VICTORIA Rejoins SIX ESG Indices After Rating Upgrade

Sep 23, 2026

AEVIS VICTORIA SA has been reinstated into five ESG indices of SIX Swiss Exchange following the latest review, reflecting improved transparency and sustainability reporting that also led to an upgraded ESG rating from Inrate, rising from B- to B. The...

Swiss Medical Network lifts profitability sharply in first half of 2026

Sep 7, 2026

Swiss Medical Network, majority-owned by AEVIS VICTORIA SA, reported a sharp improvement in profitability in the first half of 2026, supported by operational efficiencies and the expansion of outpatient and primary healthcare services. In its healthc...

AEVIS VICTORIA broadens shareholder base with CHF 12.4m share placement

Sep 4, 2026

AEVIS VICTORIA SA has placed two share blocks of 500,000 shares each, totalling 1,000,000 shares or about 1.4% of its capital, with a long‑term institutional fund at CHF 12.40 per share for a value of CHF 12.4 million. The shares originate from a for...

AEVIS VICTORIA boosts free float with CHF 12.4m share placement

Aug 25, 2026

AEVIS VICTORIA SA has placed a package of 1,000,000 existing shares, representing about 1.2% of its share capital, with the Demole family’s Family Office via a stock exchange transaction at CHF 12.40 per share. The move brings a new long-term oriente...

MRH Switzerland Outperforms Soft Swiss Hotel Market with Higher Rates and Stable Margins

Aug 3, 2026

MRH Switzerland AG, the hotel arm of AEVIS VICTORIA, posted a 1.0% revenue increase to CHF 104.9 million in the first half of 2026, despite a slightly contracting Swiss hotel market. Accommodation and restaurant revenues both edged higher, with avera...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 23, 2026

AEVIS VICTORIA SA AI Stock Analysis